Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery
| Status: | Terminated |
|---|---|
| Conditions: | Colorectal Cancer, Cancer, Colitis, Gastrointestinal, Crohns Disease |
| Therapuetic Areas: | Gastroenterology, Oncology |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 3/20/2019 |
| Start Date: | April 17, 2018 |
| End Date: | January 9, 2019 |
The primary objectives of this study are to evaluate the potential for preoperative
pharmacogenomics (PGx) testing to positively influence postoperative opioid use through
visual analog scale (VAS) guided administration of narcotic equivalent and lower pain scores
as measured by OBAS in patients undergoing major abdominal surgery.
pharmacogenomics (PGx) testing to positively influence postoperative opioid use through
visual analog scale (VAS) guided administration of narcotic equivalent and lower pain scores
as measured by OBAS in patients undergoing major abdominal surgery.
Inclusion Criteria:
- Subject capable of giving consent
- Age 18-80
- Scheduled for open colorectal resection at Cleveland Clinic main campus (with
preoperative appointment scheduled at least five days before date of surgery)
Exclusion Criteria:
- Patient does not speak English
- Patient with substance-use disorder (including alcohol)
- Patient diagnosed with major depression
- Patient currently taking opioids
- Previous long-term opioid use (> 3 months)
- Previous opioid use with a dose of >100 milligram morphine equivalent (MME)
- Patient has pain-related disorder (e.g. fibromyalgia, sympathetic dystrophy, etc.)
- Documented allergy to pain medication
We found this trial at
1
site
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
Click here to add this to my saved trials
